Brief: Eiger BioPharmaceuticals Q1 product revenue USD 4.118 million
11/05/2023 21:00
May 11 (Reuters) - Eiger BioPharmaceuticals Q1 product revenue USD 4.118 million. * Q1 operating expenses USD 26.381 million * Q1 net income USD -22.784 million * Q1 operating income USD -22.263 million
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview